Rating History for Adamas Pharmaceuticals (ADMS) by Northland
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 11/17/2021 | Carl Byrnes | Downgrade | Market Perform (Outperform) |
8.50 (N/A) |
8.15 (8.22) |
0.86% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
